Skip to main content
GENB filings

Corporate insider profile

Frances Arnold Filing Activity

Latest reported as Director of Generate Biomedicines, Inc. (GENB).

Purchase filings
0
Reported companies
2
Net open-market value
-$187,079.56
Latest transaction
Sep 1, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 1, 2026Generate Biomedicines, Inc. (GENB)DirectorSale1,000$16.00$16,002
Aug 28, 2026Alphabet Inc. (GOOGL)DirectorSale82$337.71$27,692
Jul 30, 2026Alphabet Inc. (GOOGL)DirectorSale82$333.39$27,338